MyPharmacy+

Efacid Suspension

Manufactured By Strassenburg Pharmaceuticals.Ltd

Salt Synonyms

Rs. 119.23

MRP 125.50

(5% OFF)

Includes all taxes

Package SIZE

bottle of 200 ml Suspension

Price may vary depending on the product batch*

100% Authentic
Products

Free
Shipping*

Products
Return Policy

Information about Efacid Suspension

Uses / Indications:

Introduction:

Efacid suspension is a therapeutic digestive medication containing a balanced mix of Magaldrate Sodium alginate and Magnesium Aluminium Silicate Hydrate. Role of key ingredients:Magaldrate rapidly neutralizes or buffers existing acid in stomach. Helps to treat indigestion heartburn gas and other digestive problems.Sodium alginate helps form a barrier that floats on top of the acid in your stomach. This barrier helps prevent stomach acid from moving up into your esophagus.Magnesium Aluminium Silicate Hydrate is a laxative that increases water in the intestine and reduces stomach acid. Usage:Efacid suspension is helpful in providing relief from peptic ulcer gastritis heartburn esophagitis and other dyspeptic conditions associated with hyperacidity. Directions of use:For immediate effect consume 1-2 teaspoonful of Efacid after meals. Use after properly shaking the bottle. Use under Medical supervision.

Efacid Suspension

Manufactured By Strassenburg Pharmaceuticals.Ltd

Salt Synonyms

Rs. 119.23

MRP 125.50

Includes all taxes

Package SIZE

Available Substitutes

112 Saal ki Burhia ki Ghuti

Vaidya Revati Prasad

1ratti Abhayarishta (450ml Each)

1ratti- Ratti Ratti Me Purity

1ratti Balarishta (450ml Each)

1ratti- Ratti Ratti Me Purity

1ratti Dashmoolarishta (450ml Each)

1ratti- Ratti Ratti Me Purity

1ratti Shankh Bhasma

1ratti- Ratti Ratti Me Purity

Uses / Indications:

Introduction:

How to use:

Description:

Benefits:

Safety Advise:

If you miss a dose:

Fact Box:

Primary Use:

Common Side Effects:

Alcohol Interaction:

Pregnancy Interaction:

Lactation Interaction:

Driving Interaction:

Kidney Interaction:

Liver Interaction:

Q&A: